15 octubre 2015
Light has been used for the first time to activate a receptor for which the compound binding and controlling it naturally is unknown, researchers suggests. A team of scientists has now employed its novel application of optogenetics to identify a new compound that inhibits the orphan receptor ROS1, which has been linked to several forms of cancer.
http://www.sciencedaily.com/releases/2015/10/151015120023.htm
